pain in feet; pains in arms/ pain in hand; pain in shoulder; sars-cov-2 infection; drug ineffective; swelling of feet; this is a spontaneous report received from a contactable reporter(s) (consumer or other non hcp) from the regulatory authority (ra). regulatory number: gb-ra-webcovid-202202161129578450-im6cw (ra). other case identifier(s): gb-ra-adr 26609716 (ra). a 45-year-old female patient (not pregnant) received bnt162b2 (pfizer-biontech covid-19 vaccine; lot number and expiration date were not reported), via an unspecified route of administration on 22may2021 (at the age of 45-years-old) as dose 1, single for covid-19 immunization. the patient's relevant medical history and concomitant medications were not reported. the following information was reported: covid-19 (medically significant) with onset 02aug2021, outcome "recovered", described as "sars-cov-2 infection"; drug ineffective (medically significant) with onset 02aug2021, outcome "unknown", described as "drug ineffective"; peripheral swelling (medically significant) with onset 22may2021, outcome "recovered" (05jun2021), described as "swelling of feet"; pain in extremity (medically significant), outcome "unknown", described as "pain in feet"; pain in extremity (medically significant), outcome "unknown", described as "pains in arms/ pain in hand"; arthralgia (medically significant), outcome "unknown", described as "pain in shoulder". the patient underwent the following laboratory tests and procedures: sars-cov-2 test: (07aug2021) positive. patient is not pregnant; patient is not currently breastfeeding. patient is not enrolled in clinical trial. no follow-up attempts are possible; information about lot/batch number cannot be obtained. no further information is expected.; sender's comments: linked report(s) : gb-pfizer inc-202200307665 same patient/drug and different dose/event